Incidence Patterns and Outcomes for Hodgkin Lymphoma Patients in the United States
Table 1
Age-adjusted incidence rates of Hodgkin lymphomas by subtype, 17 SEER registries, 2000–2007.
Incidence rate rati
Male
Female
Hodgkin lymphoma subtype
ICD-O-3 codes
Count
Age-adjusted incidence rate (CI)
Black
Asian/PI
Black
Asian/PI
Classical Hodgkin lymphoma
9650–9655, 9661–9667
15,895
2.63 (2.59–2.67)
0.86 (0.79–0.93)
0.45 (0.40–0.49)
0.79 (0.73–0.85)
0.41 (0.36–0.46)
Lymphocyte-rich
9651
501
0.08 (0.07–0.09)
0.96 (0.65–1.39)
0.57 (0.32–0.93)
1.56 (0.99–2.37)
0.61 (0.27–1.19)
Mixed cellularity
9652
2,197
0.39 (0.35–0.39)
0.99 (0.83–1.19)
0.45 (0.34–0.59)
0.89 (0.69–1.13)
0.43 (0.29–0.61)
Lymphocyte-depleted
9653–9655
225
0.04 (0.03–0.04)
0.78 (0.40–1.41)
0.62 (0.25–1.28)
0.76 (0.29–1.65)
0.28 (0.03–1.01)
Nodular sclerosis
9663–9667
9,927
1.63 (1.59–1.66)
0.74 (0.66–0.82)
0.43 (0.37–0.49)
0.72 (0.65–0.79)
0.41 (0.35–0.47)
Classical Hodgkin lymphoma, NOS
9650, 9661, 9662
3,045
0.51 (0.49–0.53)
1.08 (0.92–1.26)
0.45 (0.34–0.57)
0.92 (0.76–1.11)
0.37 (0.27–0.49)
Nodular lymphocyte predominant Hodgkin lymphoma
9659
654
0.11 (0.10–0.12)
1.66 (1.27–2.14)
0.44 (0.25–0.71)
2.84 (2.02–3.95)
0.67 (0.31–1.28)
Hodgkin lymphoma
9650–9655, 9659, 9661–9667
16,549
2.74 (2.69–2.78)
0.89 (0.83–0.96)
0.45 (0.40–0.49)
0.83 (0.77–0.89)
0.41 (0.37–0.46)
Abbreviations: ICD-O: international classification of diseases for oncology; CI: 95% confidence interval; PI: Pacific islanders; NOS: not otherwise specified Ratio of age-adjusted incidence rates Black/White and Asian/White.
